Developing as a promising development in the battle against obesity, this medication is generating considerable interest . It combines the action of two known GLP-1 binding agonists, dulaglutide , plus an additional glucose-dependent hormonal component. Preliminary patient findings have shown substantial fat loss in patients with excessive weig… Read More